Remarkably, a few organizations are retaliating against plans for Federal medical insurance to start arranging the costs of the costliest medications.
The biotech bunch positions eighth out of 197 industry bunches that IBD tracks. In the interim, the pharma bunch positions No. 85.
But when looking at stocks, it’s important to keep an eye on specific measures. The best biotech stocks currently trading above 10 on fundamental and technical metrics are: Amphastar Drugs (AMPH) Impetus Drugs (CPRX) Neurocrine Biosciences (NBIX) Vertex Drugs (VRTX) Immunogen (IMGN).